CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, today announced a $65 million ...
James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results